Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter
- Details
- Category: Abbott

Pediatric Exclusivity For PLAVIX®
- Details
- Category: Bristol-Myers Squibb

GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
- Details
- Category: GlaxoSmithKline

AstraZeneca Replies to FDA Complete Response Letter for BRILINTA
- Details
- Category: AstraZeneca

Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
- Details
- Category: Genzyme

The clinical phase III programme commenced on zicronapine
- Details
- Category: Lundbeck

Roche personalized investigational medicine shows survival benefit in advanced skin cancer
- Details
- Category: Roche

More Pharma News ...
- Bayer and Regeneron start MYRROR Phase III Trial
- Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
- GlaxoSmithKline announces Q4 2010 legal charge
- European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
- Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance
- Sandoz announces phase II clinical trial for biosimilar version of rituximab
- GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786